NRx: Potent Antibacterial Activity v. Common, Antibiotic Resistant Urinary Pathogens

 

• NRX-101 demonstrated potent antibacterial effect against antibiotic-resistant pathogens in culture medium and in an artificial urine model
• D-cycloserine (DCS), a key component of NRX-101, was originally developed as an anti-infective in the 1950's but was replaced by antibiotics that have since lost effectiveness against complicated Urinary Tract Infections (cUTI)
• In an era when 90% of cUTI pathogens demonstrate resistance to standard antibiotics, NRX-101 may prove effective in treating cUTI and preventing urosepsis

https://www.biospace.com/article/releases/nrx-pharmaceuticals-announces-potent-antibacterial-activity-of-nrx-101-against-common-antibiotic-resistant-urinary-pathogens/